Charles Schwab
PKBO

Charles Schwab’s Peak Bio, Inc. Common Stock PKBO Stock Holding History

Charles Schwab’s Portfolio PKBO Stock Details PKBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-38,631
Closed -$162K – 3644
2022
Q4 		$162K Buy
+38,631
New +$268K ﹤0.01% 3214

Other funds holding PKBO

PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Charles Schwab's PKBO Position: Q1 2023 in Review

Charles Schwab sold out of Peak Bio, Inc. Common Stock (PKBO) in Q1 2023, closing a stake of 38,631 shares — an estimated $162K sold.

Charles Schwab first reported a position in PKBO in Q4 2022 and held it in 1 quarter. The position peaked at $162K in Q4 2022. 1 fund tracked by Wall St. Rank holds PKBO as of Q1 2023.

  • Charles Schwab reported no remaining Peak Bio, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Charles Schwab sold 38,631 Peak Bio, Inc. Common Stock shares in Q1 2023, an estimated $162K.
  • Charles Schwab first reported a position in Peak Bio, Inc. Common Stock in Q4 2022 and held it in 1 quarter.
  • Charles Schwab's Peak Bio, Inc. Common Stock position peaked at $162K in Q4 2022.
  • 1 fund tracked by Wall St. Rank held Peak Bio, Inc. Common Stock as of Q1 2023.

Based on Charles Schwab's 13F filing for Q1 2023, filed 12 May 2023.